Cue Biopharma Inc logo

Cue Biopharma Inc

$ 3.28 -0.29 (-8.12%) 10:08 PM EST
P/E:
At Loss
P/B:
2.28
Market Cap:
$ 116.06M
Enterprise V:
$ 86.76M
Volume:
199.57K
Avg Vol (2M):
140.44K
Also Trade In:
Volume:
199.57K
Market Cap $:
116.06M
PE Ratio:
At Loss
Avg Vol (2-Month):
140.44K
Enterprise Value $:
86.76M
PB Ratio:
2.28
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401.
Name Current Vs Industry Vs History
Cash-To-Debt 3.02
Equity-to-Asset 0.67
Debt-to-Equity 0.39
Debt-to-EBITDA -0.44
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.41
Distress
Grey
Safe
Beneish M-Score -2.96
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 29.16
9-Day RSI 41.99
14-Day RSI 47.65
6-1 Month Momentum % -13.39
12-1 Month Momentum % -69.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.04
Quick Ratio 6.04
Cash Ratio 5.79
Days Sales Outstanding 49.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.9

Financials (Next Earnings Date:2023-02-14 Est.)

CUE's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with NAS:CUE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 9.348
EPS (TTM) ($) -1.37
Beta 1.88
Volatility % 82.43
14-Day RSI 47.65
14-Day ATR ($) 0.337664
20-Day SMA ($) 3.4555
12-1 Month Momentum % -69.92
52-Week Range ($) 2.18 - 12.79
Shares Outstanding (Mil) 35.39

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cue Biopharma Inc Filings

Document Form Filing Date
No Filing Data

Cue Biopharma Inc Analysis

Share your research

Headlines

See More
No news.